Altitude Life Science Ventures

Altitude Life Science Ventures

Altitude Life Science Ventures

Follow us
$180,000,000 IPO
MedCity News

Beam Therapeutics raises $180M in IPO

Xconomy

Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered

FinSMEs

Omniome Raises $60M in Series C Financing

the home of AI info

BlackThorn Therapeutics Reports New Insights into Neurobehavioral Disorders at the 49

MedCity News

Gene editing company Beam Therapeutics aims for $100M IPO

Xconomy

Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs

$135,000,000 Venture capital (Series B)
FinSMEs

Beam Therapeutics Secures $135M in Series B Financing

$30,000,000 Venture capital
FinSMEs

OvaScienceSM and Millendo Therapeutics Merge; New Company Raises $30M

Funding Strategy Science
$60,000,000 Venture capital (Series B)
PE HUB

Omniome fetches $60 mln

Messaging
FinSMEs

Novel Genomic Sequencing Technology Omniome Closes $60M Series B

Science Funding
$60,000,000 IPO
PE HUB

VC-backed Constellation Pharmaceuticals rolls out IPO

Stock markets Funding Health
Xconomy

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M

Science
$87,000,000 Venture capital (Series A)
FinSMEs , PE HUB , MedCity News

Beam Therapeutics Raises up to $87M in Series A Financing

Science Education
$100,000,000 Venture capital
FinSMEs , PE HUB

Constellation Pharmaceuticals Raises $100M Financing

Funding Health Science
Xconomy

Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials

Health Funding Science
$55,000,000 Venture capital (Series C)
FinSMEs

Unity Biotechnology Completes $55M Series C Financing

Funding Health
$35,000,000 Venture capital (Series B)
PE HUB

Unity Biotechnology snags $35 mln Series B

Messaging
$38,600,000 Venture capital (Series C)
Xconomy , vcaonline

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Funding Health Science
PE HUB

Vividion Therapeutics picks up $50 mln Series A

Funding Messaging
$50,000,000 Venture capital (Series A)
businesswire

Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing